ArticleAdvanced materials (Deerfield Beach, Fla.)2026
An Injectable Magneto-Responsive Periosteum Reprograms Neutrophil Extracellular Trap Formation for Osteomyelitis Treatment.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Osteomyelitis caused by methicillin-resistant Staphylococcus aureus (MRSA) biofilms presents significant therapeutic challenges due to antibiotic resistance and persistent bacterial presence. Inspired by the natural periosteum structure, we developed an injectable biomimetic periosteum through thiol-click chemistry-a hydrogel loaded with NiSr MOF@Mem nanocomposites(NiSr MOF@Mem Gel). This system not only serves as a physical barrier covering bone defects but also, under alternating magnetic field (MF) activation, synergistically executes chemodynamic therapy, controlled antibiotic release, and immunomodulation. In vitro studies demonstrated that this biomimetic periosteum activates NADPH oxidase-dependent ROS bursts under MF, driving PAD4-mediated histone H3 citrullination and thereby inducing neutrophil extracellular trap (NET) formation. This process relies on the classical ROS/PAD4 signaling axis, as confirmed by the PAD4 inhibitor Cl-Amidine significantly suppressing NETosis. Functional assays verified that the system, via NET induction, exerts potent synergistic antibacterial effects against both planktonic and biofilm-embedded MRSA. In a rat osteomyelitis model, the biomimetic periosteum combined with MF treatment significantly reduced bacterial load in bone tissue and effectively promoted bone repair by modulating the immune microenvironment. This study presents a novel strategy of using a magnetically responsive biomimetic periosteum to remotely regulate innate immunity for biofilm eradication, offering an integrated solution for the synergistic treatment of osteomyelitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.